Detalhe da pesquisa
1.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947974
2.
Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1.
Oncologist
; 28(1): e77-e81, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342342
3.
Autologous Reconstruction After Failed Implant-Based Breast Reconstruction: A Comparative Multifactorial Outcome Analysis.
Ann Plast Surg
; 91(1): 42-47, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450860
4.
The Partner Perspective on Autologous and Implant-Based Breast Reconstruction.
Aesthetic Plast Surg
; 47(4): 1324-1331, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820865
5.
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Ann Surg
; 276(5): e553-e562, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156057
6.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657944
7.
The Search for the Ideal Female Breast: A Nationally Representative United-States-Census Study.
Aesthetic Plast Surg
; 46(4): 1567-1574, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35043247
8.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252375
9.
The INTREST registry: protocol of a multicenter prospective cohort study of predictors of women's response to integrative breast cancer treatment.
BMC Cancer
; 21(1): 724, 2021 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162339
10.
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis.
Br J Cancer
; 123(1): 33-37, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367072
11.
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial.
Support Care Cancer
; 28(8): 3605-3615, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828488
12.
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Breast Cancer Res
; 21(1): 60, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077239
13.
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis.
Br J Cancer
; 120(3): 301-305, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655614
14.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093166
15.
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
BMC Cancer
; 18(1): 851, 2018 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144818
16.
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 141-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519041
17.
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer.
Eur J Cancer
; 198: 113480, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154393
18.
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
JAMA Oncol
; 10(6): 793-798, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662396
19.
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer.
Breast Cancer Res
; 15(1): R11, 2013 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391338
20.
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany.
Ther Adv Med Oncol
; 15: 17588359231200454, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789989